Health Promot Perspect. 2020;10(2): 98-115. doi: 10.34172/hpp.2020.18
PMID: 32296622        PMCID: PMC7146037

Systematic Review

Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis

Majid Mobasseri 1 ORCID, Masoud Shirmohammadi 2, Tarlan Amiri 3, Nafiseh Vahed 4,5, Hossein Hosseini Fard 5, Morteza Ghojazadeh 5 * ORCID

Cited by CrossRef: 117

1- Kurtzhals P, Nishimura E, Haahr H, Høeg-Jensen T, Johansson E, Madsen P, Sturis J, Kjeldsen T. Commemorating insulin's centennial: engineering insulin pharmacology towards physiology. Trends in Pharmacological Sciences. 2021;42(8):620 [Crossref]
2- Longo M, Scappaticcio L, Petrizzo M, Castaldo F, Sarnataro A, Forestiere D, Caiazzo F, Bellastella G, Maiorino M, Capuano A, Esposito K. Glucose control in home-isolated adults with type 1 diabetes affected by COVID-19 using continuous glucose monitoring. J Endocrinol Invest. 2022;45(2):445 [Crossref]
3- Koprivica I, Jonić N, Diamantis D, Gajić D, Saksida T, Pejnović N, Tzakos A, Stojanović I. Phenethyl ester of rosmarinic acid attenuates autoimmune responses during type 1 diabetes development in mice. Life Sciences. 2022;288:120184 [Crossref]
4- Muammar T, Fojas E, Helal R, Lessan N. Ramadan Fasting Among Older Children and Adolescents With Type 1 Diabetes Mellitus: A Real-World Study From the UAE. Front Nutr. 2022;9 [Crossref]
5- Verhoeff K, Henschke S, Marfil-Garza B, Dadheech N, Shapiro A. Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes. Cells. 2021;10(2):278 [Crossref]
6- Elliott T, Pfotenhauer K. Classification and Diagnosis of Diabetes. Primary Care: Clinics in Office Practice. 2022;49(2):191 [Crossref]
7- Karim R, Vassányi I, Kósa I. Improved Methods for Mid-Term Blood Glucose Level Prediction Using Dietary and Insulin Logs. Medicina. 2021;57(7):676 [Crossref]
8- Alberti A, Schuelter-Trevisol F, Iser Betine P, Traebert E, Freiberger V, Ventura L, Rezin G, da Silva B, Meneghetti Dallacosta F, Grigollo L, Dias P, Fin G, De Jesus J, Pertille F, Rossoni C, Hur Soares B, Nodari Júnior R, Comim C. Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken. WJCC. 2021;9(20):5358 [Crossref]
9- Ryan P, Zahradnik M, Konnyu K, Rader T, Halasy M, Shulman R, Ivers N, Hawkes C, Grimshaw J. Effectiveness of quality improvement strategies for type 1 diabetes in children and adolescents: a systematic review protocol. HRB Open Res. 2021;4:87 [Crossref]
10- Van Hulten V, Rasmussen N, Driessen J, Burden A, Kvist A, van den Bergh J. Fracture Patterns in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review of Recent Literature. Curr Osteoporos Rep. 2021;19(6):644 [Crossref]
11- Díez-Manglano J, Asìn Samper U. Type-1 diabetes and pulmonary function tests. A meta-analysis. Respiratory Medicine. 2022;203:106991 [Crossref]
12- Alshurtan K, Alnizari O, Aldarwish H, Al-Tufaif A. Efficacy and Safety of Intravenous Insulin in Treatment of Patient With Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis. 2022; [Crossref]
13- Maffeis C, Mancioppi V, Piona C, Avossa F, Fedeli U, Marigliano M. Type 1 diabetes prevalence and incidence rates in the pediatric population of Veneto Region (Italy) in 2015–2020. Diabetes Research and Clinical Practice. 2021;179:109020 [Crossref]
14- Zhang M, Flores K, Tran H. Deep learning and regression approaches to forecasting blood glucose levels for type 1 diabetes. Biomedical Signal Processing and Control. 2021;69:102923 [Crossref]
15- Tran P, Kim E, Tran L, Khaled B, Hopkins D, Gardiner M, Bryant J, Bernard R, Morgan J, Bode B, Reed J, She J, Purohit S. T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications. IJERPH. 2021;18(21):11094 [Crossref]
16- Titoria R, Amed S, Tang T. Peer Support Interventions on Digital Platforms for Children With Type 1 Diabetes and Their Caregivers. 2022;35(1):26 [Crossref]
17- Schoelwer M, DeBoer M. Artificial Pancreas Technology Offers Hope for Childhood Diabetes. Curr Nutr Rep. 2021;10(1):47 [Crossref]
18- Pearson J, Wong F, Wen L. Inflammasomes and Type 1 Diabetes. Front Immunol. 2021;12 [Crossref]
19- Ojo O, Amanze J, Oni A, Grant S, Iyobhebhe M, Elebiyo T, Rotimi D, Asogwa N, Oyinloye B, Ajiboye B, Ojo A. Antidiabetic activity of avocado seeds (Persea americana Mill.) in diabetic rats via activation of PI3K/AKT signaling pathway. Sci Rep. 2022;12(1) [Crossref]
20- Verhoeff K, Cuesta-Gomez N, Jasra I, Marfil-Garza B, Dadheech N, Shapiro A. Optimizing Generation of Stem Cell-Derived Islet Cells. Stem Cell Rev and Rep. 2022;18(8):2683 [Crossref]
21- Pinna F, Suprani F, Deiana V, Lai L, Manchia M, Paribello P, Somaini G, Diana E, Nicotra E, Farci F, Ghiani M, Cau R, Tuveri M, Cossu E, Loy E, Crapanzano A, Grassi P, Loviselli A, Velluzzi F, Carpiniello B. Depression in Diabetic Patients: What Is the Link With Eating Disorders? Results of a Study in a Representative Sample of Patients With Type 1 Diabetes. Front Psychiatry. 2022;13 [Crossref]
22- Bensussen A, Santana M, Rodríguez-Jorge O. Metabolic alterations impair differentiation and effector functions of CD8+ T cells. Front Immunol. 2022;13 [Crossref]
23- Marcus C, Danielsson P, Hagman E. Pediatric obesity—Long‐term consequences and effect of weight loss. J Intern Med. 2022;292(6):870 [Crossref]
24- Hua W, Hou J, Jiang T, Su B, Fu J, Sun R, Chang B, Xia W, Wu H, Zhang T, Guo C, Wang W. The Longitudinal Association Between Cardiovascular Risk and Cognitive Function in Middle-Aged and Older Adults in China: A Nationally Representative Cohort Study. Front Cardiovasc Med. 2020;7 [Crossref]
25- Niedobylski S, Skarbek M, Tomasik J, Zaręba B, Zawadzka Ż, Próchnicki M, Rudzki G. Eating disorders and carbohydrate metabolism interrelations. 2022;23(2):80 [Crossref]
26- Jebraeili H, Shabbidar S, Sajjadpour Z, Aghdam S, Qorbani M, Rajab A, Sotoudeh G. The association between carbohydrate quality index and anthropometry, blood glucose, lipid profile and blood pressure in people with type 1 diabetes mellitus: a cross-sectional study in Iran. J Diabetes Metab Disord. 2021;20(2):1349 [Crossref]
27- Bhuiyan S, Badran H. The Impact of COVID‐19 Pandemic on Diabetic Children: A Systematic Review on the Current Evidence. IJCMHE. 2020;:1 [Crossref]
28- Frommer L, Kahaly G. Type 1 diabetes and associated autoimmune diseases. WJD. 2020;11(11):527 [Crossref]
29- Xie J, Chen G, Liang T, Li A, Liu W, Wang Y, Wang X, Kuang X, Han D, Liao W, Song L, Zhang X. Childhood asthma and type 1 diabetes mellitus: A meta‐analysis and bidirectional Mendelian randomization study. Pediatric Allergy Immunology. 2022;33(9) [Crossref]
30- Pintaudi B, Nani A, Gironi I, Bertuzzi F. Advanced technology for type 1 diabetes care in a deaf-mute patient. BMJ Case Rep. 2022;15(1):e245336 [Crossref]
31- Al Hayek A, Al Dawish M. Patient-Reported Preference and Clinical Efficacy of Insulin Pen Devices With Safety Needles in Adolescents and Young Adults With Type 1 Diabetes: A Prospective Study. 2021; [Crossref]
32- Hatipoğlu Ö, Önsüren A, Hatipoğlu F, Kurt A. Caries‐related salivary parameters and oral microbial flora in patients with type 1 diabetes: A meta‐analysis. Diabetes Metabolism Res. 2022;38(5) [Crossref]
33- Travis C, Srivastava P, Hawke T, Kalaitzoglou E, Stratmann B. Diabetic Bone Disease and Diabetic Myopathy: Manifestations of the Impaired Muscle-Bone Unit in Type 1 Diabetes. Journal of Diabetes Research. 2022;2022:1 [Crossref]
34- Sgrazzutti L, Sansone F, Attanasi M, Di Pillo S, Chiarelli F. Coaggregation of Asthma and Type 1 Diabetes in Children: A Narrative Review. IJMS. 2021;22(11):5757 [Crossref]
35- Ishaq H, Ibrahim M, Ismail A, Abubaker N, M Elfaki E. Assessment of Specific and Non-specific Autoantibodies among Newly Diagnosed Type 1 Diabetes Mellitus Sudanese Patients. Biomed Pharmacol J. 2022;15(3):1477 [Crossref]
36- Yen P, Young A. Review of Modern Insulin Pumps and the Perioperative Management of the Type 1 Diabetic Patient for Ambulatory Dental Surgery. 2021;68(3):180 [Crossref]
37- Raicevic M, Samardzic M, Soldatovic I, Curovic Popovic N, Vukovic R. Trends in nationwide incidence of pediatric type 1 diabetes in Montenegro during the last 30 years. Front Endocrinol. 2022;13 [Crossref]
38- Szabłowski M, Okruszko M, Pochodowicz K, Abramowicz P, Konstantynowicz J, Bossowski A, Głowińska-Olszewska B. Coincidence of juvenile idiopathic arthritis and type 1 diabetes: a case-based review. Rheumatol Int. 2022;42(2):371 [Crossref]
39- Mussa B, Venkatachalam T, Srivastava A, Al-Habshi A, Abdelgadir E, Bashier A, Al Awadi F, Hafidh K, Hamoudi R, Abusnana S. Identification of novel differentially expressed genes in type 1 diabetes mellitus complications using transcriptomic profiling of UAE patients: a multicenter study. Sci Rep. 2022;12(1) [Crossref]
40- Mokhtariye A, Dadashi A, Vahidi M, Malekabad E, Yaghoubi Naei V, Khorramnia S. Association of p53 (P72R) gene polymorphism with increased risk of diabetes mellitus in center of Iran (Tehran). Gene Reports. 2021;23:101164 [Crossref]
41- Dubey S, Chiao J. Implantable Radio Frequency Powered Gastric Electrical Stimulator. IEEE J Electromagn RF Microw Med Biol. 2022;6(3):340 [Crossref]
42- Park Y, Yang C, Cho H. Therapeutic Effects of Insulin-Producing Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Type 1 Diabetes Mouse Model. IJMS. 2022;23(13):6877 [Crossref]
43- ELMAOĞULLARI S, YİLDİRİM N, SAVAŞ ERDEVE Ş, AYCAN Z, ÇETİNKAYA S. 2015-2019 yılları arasında çocuk endokrinoloji servisine yatırılmış diyabetes mellitus tanılı olguların yatış durumlarının değerlendirilmesi. 2021; [Crossref]
44- Liu S, Larsson H, Lichtenstein P, Ludvigsson J, Gudbjörnsdottir S, Serlachius E, Kuja‐Halkola R, Butwicka A. Childhood‐onset type 1 diabetes and attention‐deficit/hyperactivity disorder with educational attainment: A population‐based sibling‐comparison study. Acta Paediatrica. 2022;111(11):2131 [Crossref]
45- Campos M, Volpon J, Ximenez J, Franttini A, Dalloul C, Sousa-Neto M, Silva R, Kacena M, Zamarioli A. Vibration therapy as an effective approach to improve bone healing in diabetic rats. Front Endocrinol. 2022;13 [Crossref]
46- Kaptein F, Kiefer B, Cully A, Celiktutan O, Bierman B, Rijgersberg-peters R, Broekens J, Van Vught W, Van Bekkum M, Demiris Y, Neerincx M. A Cloud-based Robot System for Long-term Interaction: Principles, Implementation, Lessons Learned. J Hum-Robot Interact. 2022;11(1):1 [Crossref]
47- AlBurno H, Schneider F, de Vries H, Al Mohannadi D, Mercken L. Determinants of adherence to insulin and blood glucose monitoring among adolescents and young adults with type 1 diabetes in Qatar: a qualitative study. F1000Res. 2022;11:907 [Crossref]
48- Yim C, Mansell K, Hussein N, Arnason T. Current cancer therapies and their influence on glucose control. WJD. 2021;12(7):1010 [Crossref]
49- Nigam S, Bishop J, Hayat H, Quadri T, Hayat H, Wang P. Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances. Pharmaceutics. 2022;14(3):644 [Crossref]
50- Glover K, Mishra D, Singh T. Epidemiology of Ocular Manifestations in Autoimmune Disease. Front Immunol. 2021;12 [Crossref]
51- Khalil R, Abdel-Moneim A, Arafa A, Allam G, El-Senousy W, Mabrouk D. Possible association of rotavirus IgG with cytokine expression levels and dyslipidemia in rotavirus-infected type 1 diabetic children. Mol Biol Rep. 2022;49(8):7587 [Crossref]
52- Hoft S, Noto C, DiPaolo R. Two Distinct Etiologies of Gastric Cancer: Infection and Autoimmunity. Front Cell Dev Biol. 2021;9 [Crossref]
53- Daskalopoulou M, Pylli M, Giannakou K. Vitamin D Deficiency as a Possible Cause of Type 1 Diabetes in Children and Adolescents up to 15 Years Old: A Systematic Review. Review of Diabetic Studies. 2022;18(2):58 [Crossref]
54- Azimi N, Ozgoli G, Ebadi A, Majd H, Rajab A, Kiani Z, Bazzazian S, Mokhtaryan-Gilani T. Development and psychometric assessment of the sexual-reproductive health profile of women with type-1 diabetes mellitus. BMC Public Health. 2022;22(1) [Crossref]
55- Corsenac P, Parent M, Mansaray H, Benedetti A, Richard H, Stäger S, Rousseau M. Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood. Diabetes & Metabolism. 2022;48(3):101337 [Crossref]
56- Perfect M, Silva G, Chin C, Wheeler M, Frye S, Mullins V, Quan S. Extending sleep to improve glycemia: The Family Routines Enhancing Adolescent Diabetes by Optimizing Management (FREADOM) randomized clinical trial protocol. Contemporary Clinical Trials. 2023;124:106929 [Crossref]
57- Räisänen L, Kääriäinen S, Sund R, Engberg E, Viljakainen H, Kolho K. Antibiotic exposures and the development of pediatric autoimmune diseases: a register-based case–control study. Pediatr Res. 2022; [Crossref]
58- Tsai D, Flores Garcia J, Fogel J, Wee C, Reid M, Raymond J. Diabetes Technology Experiences Among Latinx and Non-Latinx Youth with Type 1 Diabetes. J Diabetes Sci Technol. 2022;16(4):834 [Crossref]
59- Rojas M, Heuer L, Zhang W, Chen Y, Ridgway W. The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes. Front Immunol. 2022;13 [Crossref]
60- Makam A, Biswas A, Kothegala L, Gandasi N. Setting the Stage for Insulin Granule Dysfunction during Type-1-Diabetes: Is ER Stress the Culprit?. Biomedicines. 2022;10(11):2695 [Crossref]
61- Harlid S, Van Guelpen B, Qu C, Gylling B, Aglago E, Amitay E, Brenner H, Buchanan D, Campbell P, Cao Y, Chan A, Chang‐Claude J, Drew D, Figueiredo J, French A, Gallinger S, Giannakis M, Giles G, Gunter M, Hoffmeister M, Hsu L, Jenkins M, Lin Y, Moreno V, Murphy N, Newcomb P, Newton C, Nowak J, Obón‐Santacana M, Ogino S, Potter J, Song M, Steinfelder R, Sun W, Thibodeau S, Toland A, Ugai T, Um C, Woods M, Phipps A, Harrison T, Peters U. Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases. Intl Journal of Cancer. 2022;151(3):348 [Crossref]
62- Wang Y, Chen J, Sang T, Chen C, Peng H, Lin X, Zhao Q, Chen S, Eling T, Wang X. NAG-1/GDF15 protects against streptozotocin-induced type 1 diabetes by inhibiting apoptosis, preserving beta-cell function, and suppressing inflammation in pancreatic islets. Molecular and Cellular Endocrinology. 2022;549:111643 [Crossref]
63- Massarenti L, Aniol-Nielsen C, Enevold C, Toft-Hansen H, Nielsen C. Influence of Insulin Receptor Single Nucleotide Polymorphisms on Glycaemic Control and Formation of Anti-Insulin Antibodies in Diabetes Mellitus. IJMS. 2022;23(12):6481 [Crossref]
64- Satoh M, Hirose T, Nakayama S, Murakami T, Takabatake K, Asayama K, Imai Y, Ohkubo T, Mori T, Metoki H. Blood Pressure and Chronic Kidney Disease Stratified by Gender and the Use of Antihypertensive Drugs. JAHA. 2020;9(16) [Crossref]
65- Martínez-Ortega A, Muñoz-Gómez C, Gros-Herguido N, Remón-Ruiz P, Acosta-Delgado D, Losada-Viñau F, Pumar-López A, Mangas-Cruz M, González-Navarro I, López-Gallardo G, Bellido V, Soto-Moreno A. Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia. JCM. 2022;11(4):1039 [Crossref]
66- Alharthi A, Banaganapalli B, Hassan S, Rashidi O, Al-Shehri B, Alaifan M, Alhussaini B, Alsufyani H, Alghamdi K, Nasser K, Bin-Taleb Y, Elango R, Shaik N, Saadah O. Complex Inheritance of Rare Missense Variants in PAK2, TAP2, and PLCL1 Genes in a Consanguineous Arab Family With Multiple Autoimmune Diseases Including Celiac Disease. Front Pediatr. 2022;10 [Crossref]
67- Thornton L. Zinc transporter 8 antibody-mediated type 1 diabetes mellitus. 2022;47(8):6 [Crossref]
68- Nguyen L, Omage J, Noble K, McNew K, Moore D, Aronoff D, Doster R. Group B streptococcal infection of the genitourinary tract in pregnant and non‐pregnant patients with diabetes mellitus: An immunocompromised host or something more?. Am J Reprod Immunol. 2021;86(6) [Crossref]
69- Tatsiopoulou P, Porfyri G, Bonti E, Diakogiannis I. Priorities in the Interdisciplinary Approach of Specific Learning Disorders (SLD) in Children with Type I Diabetes Mellitus (T1DM). From Theory to Practice. Brain Sciences. 2020;11(1):4 [Crossref]
70- Ross C, Ward Z, Gomber A, Owais M, Yeh J, Reddy C, Atun R. The Prevalence of Islet Autoantibodies in Children and Adolescents With Type 1 Diabetes Mellitus: A Global Scoping Review. Front Endocrinol. 2022;13 [Crossref]
71- Sun X, Rashid M, Askari M, Cinar A. Adaptive personalized prior-knowledge-informed model predictive control for type 1 diabetes. Control Engineering Practice. 2023;131:105386 [Crossref]
72- Wang S, Liao J. Epidemiologic Implication of the Association between Herpes Simplex Virus Infection and the Risk of Type 1 Diabetes Mellitus: A Nationwide Case-Control Study in Taiwan. IJERPH. 2022;19(13):7832 [Crossref]
73- Jones J, James S, Brown F, O'Neal D, I Ekinci E. Dead in bed – A systematic review of overnight deaths in type 1 diabetes. Diabetes Research and Clinical Practice. 2022;191:110042 [Crossref]
74- Koca S, Akdogan M, Koca S. Evaluation of early retinal vascular changes by optical coherence tomography angiography in children with type 1 diabetes mellitus without diabetic retinopathy. Int Ophthalmol. 2022;42(2):423 [Crossref]
75- Tzivian L, Sokolovska J, Grike A, Kalcenaua A, Seidmann A, Benis A, Mednis M, Danovska I, Berzins U, Bogdanovs A, Syundyukov E. Quantitative and qualitative analysis of the quality of life of Type 1 diabetes patients using insulin pumps and of those receiving multiple daily insulin injections. Health Qual Life Outcomes. 2022;20(1) [Crossref]
76- Calloni C, Martínez L, Gil D, da Silva D, Jahn M, Salvador M. Jabuticaba [Plinia trunciflora (O. Berg) Kausel] Protects Liver of Diabetic Rats Against Mitochondrial Dysfunction and Oxidative Stress Through the Modulation of SIRT3 Expression. Front Physiol. 2021;12 [Crossref]
77- Khorshidi M, Sayyari A, Olang B, Alaei M, Shab-Bidar S, Khalili M, Salehi M, Aryaeian N. Study protocol of a randomized controlled clinical trial investigating the effects of omega-3 supplementation on endothelial function, vascular structure, and metabolic parameters in adolescents with type 1 diabetes. Trials. 2021;22(1) [Crossref]
78- Syed F. Type 1 Diabetes Mellitus. Ann Intern Med. 2022;175(3):ITC33 [Crossref]
79- Herranz-Antolín S, Sastre J, Gonzalvo-Díaz C, Del Val-Zaballos F, Moreno-Fernández J, González-López J, Quiroga-López I, López-Gallardo G. Prevalence of autoimmune diseases in patients with type 1 diabetes mellitus. DIACAM 1 study 2010–2020. Medicina Clínica (English Edition). 2022; [Crossref]
80- Gutaj P, Matysiak J, Matuszewska E, Jaskiewicz K, Kamińska D, Światły-Błaszkiewicz A, Szczapa T, Kalantarova A, Gajecka M, Wender-Ozegowska E. Maternal serum proteomic profiles of pregnant women with type 1 diabetes. Sci Rep. 2022;12(1) [Crossref]
81- Petino Zappala M, Folguera G, Benitez-Vieyra S. Phenotypic decanalization driven by social determinants could explain variance patterns for glycemia in adult urban Argentinian population. Sci Rep. 2022;12(1) [Crossref]
82- Jayasinghe M, Prathiraja O, Perera P, Jena R, Silva M, Weerawarna P, Singhal M, Kayani A, Karnakoti S, Jain S. The Role of Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes . 2022; [Crossref]
83- Toren E, Burnette K, Banerjee R, Hunter C, Tse H. Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis. Front Immunol. 2021;12 [Crossref]
84- Ojo O, Grant S, Amanze J, Oni A, Ojo A, Elebiyo T, Obafemi T, Ayokunle D, Ogunlakin A, Singh A. Annona muricata L. peel extract inhibits carbohydrate metabolizing enzymes and reduces pancreatic β-cells, inflammation, and apoptosis via upregulation of PI3K/AKT genes. PLoS ONE. 2022;17(10):e0276984 [Crossref]
85- Dallagiacoma G, Allora A, Salvati S, Cocciolo G, Capraro M, Lamberti A, Senatore S, Gentile L, Gianfredi V, Laurenzi A, Molinari C, Caretto A, Faccini M, Signorelli C, Scavini M, Odone A. Type 1 Diabetes Patients’ Practice, Knowledge and Attitudes towards Influenza Immunization. Vaccines. 2021;9(7):707 [Crossref]
86- Khorshidi M, Sayyari A, Aryaeian N, Olang B, Alaei M, Khalili M, Hosseini A, Salehi M. Effects of omega-3 supplementation on endothelial function, vascular structure, and metabolic parameters in adolescents with type 1 diabetes mellitus: A randomized clinical trial. Front Nutr. 2022;9 [Crossref]
87- Desoye G, Ringholm L, Damm P, Mathiesen E, van Poppel M. Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason?. Diabetologia. 2022; [Crossref]
88- Cattaneo C, Mameli C, D'Auria E, Zuccotti G, Pagliarini E. The Influence of Common Noncommunicable Diseases on Chemosensory Perception and Clinical Implications in Children and Adolescents. 2022;13(1):234 [Crossref]
89- Mertens J, De Block C, Spinhoven M, Driessen A, Francque S, Kwanten W. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy. Front Pharmacol. 2021;12 [Crossref]
90- Nekoua M, Mercier A, Alhazmi A, Sane F, Alidjinou E, Hober D. Fighting Enteroviral Infections to Prevent Type 1 Diabetes. Microorganisms. 2022;10(4):768 [Crossref]
91- Wolkowicz K, Aiello E, Vargas E, Teymourian H, Tehrani F, Wang J, Pinsker J, Doyle F, Patti M, Laffel L, Dassau E. A review of biomarkers in the context of type 1 diabetes: Biological sensing for enhanced glucose control. Bioeng Transl Med. 2021;6(2) [Crossref]
92- Ma H, Murphy C, Loscher C, O’Kennedy R. Autoantibodies - enemies, and/or potential allies?. Front Immunol. 2022;13 [Crossref]
93- Raghav A, Ashraf H, Jeong G. Engineered Extracellular Vesicles in Treatment of Type 1 Diabetes Mellitus: A Prospective Review. Biomedicines. 2022;10(12):3042 [Crossref]
94- Boutari C, Pappas P, Theodoridis T, Vavilis D. Humanin and diabetes mellitus: A review of in vitro and in vivo studies. WJD. 2022;13(3):213 [Crossref]
95- Berney T, Wassmer C, Lebreton F, Bellofatto K, Fonseca L, Bignard J, Hanna R, Peloso A, Berishvili E. From islet of Langerhans transplantation to the bioartificial pancreas. La Presse Médicale. 2022;51(4):104139 [Crossref]
96- Abugoukh T, Al Sharaby A, Elshaikh A, Joda M, Madni A, Ahmed I, Abdalla R, Ahmed K, Elazrag S, Abdelrahman N. Does Vitamin D Have a Role in Diabetes?. 2022; [Crossref]
97- Holt R, DeVries J, Hess-Fischl A, Hirsch I, Kirkman M, Klupa T, Ludwig B, Nørgaard K, Pettus J, Renard E, Skyler J, Snoek F, Weinstock R, Peters A. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 2021;44(11):2589 [Crossref]
98- Oliveira G, Alessi J, Erthal I, Teixeira J, Morello M, Ribeiro R, Telo G, Schaan B, Telo G. Healthy lifestyle gone bad: effect of the COVID-19 pandemic on the daily habits of children and adolescents with type 1 diabetes. 2022; [Crossref]
99- Sachdeva P, M. A, Shukla R, Sahani A. A review on artificial pancreas and regenerative medicine used in the management of Type 1 diabetes mellitus. Journal of Medical Engineering & Technology. 2022;46(8):693 [Crossref]
100- Kabir M, Ferdous Mitu J, Akter R, Akhtar M, Saleem A, Al-Harrasi A, Bhatia S, Rahman M, Damiri F, Berrada M, Rahman M. Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus. Environ Sci Pollut Res. 2022;29(31):46385 [Crossref]
101- Galiyeva D, Gusmanov A, Sakko Y, Issanov A, Atageldiyeva K, Kadyrzhanuly K, Nurpeissova A, Rakhimzhanova M, Durmanova A, Sarria-Santamera A, Gaipov A. Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019. BMC Endocr Disord. 2022;22(1) [Crossref]
102- Miller F. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Current Opinion in Immunology. 2023;80:102266 [Crossref]
103- Parmar C, Appel S, Lee L, Ribeiro R, Sakran N, Pouwels S. Choice of Bariatric Surgery in Patients with Obesity and Type 1 Diabetes Mellitus? an Up-to-Date Systematic Review. OBES SURG. 2022;32(12):3992 [Crossref]
104- Portincasa P, Bonfrate L, Wang D, Frühbeck G, Garruti G, Di Ciaula A. Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract. Eur J Clin Investigation. 2022;52(11) [Crossref]
105- Paez-Mayorga J, Lukin I, Emerich D, de Vos P, Orive G, Grattoni A. Emerging strategies for beta cell transplantation to treat diabetes. Trends in Pharmacological Sciences. 2022;43(3):221 [Crossref]
106- Herranz-Antolín S, Sastre J, Gonzalvo-Díaz C, Del Val-Zaballos F, Moreno-Fernández J, González-López J, Quiroga-López I, López-Gallardo G. Prevalencia de enfermedades autoinmunes en pacientes con diabetes mellitus tipo 1. Estudio DIACAM 1 2010-2020. Medicina Clínica. 2022;159(11):522 [Crossref]
107- Bloomgarden Z. Biosimilar insulin concepts. Journal of Diabetes. 2022;14(4):231 [Crossref]
108- Berezin A, Berezin A, Lichtenauer M. Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus. Front Cardiovasc Med. 2020;7 [Crossref]
109- Charoenpiriya A, Chailurkit L, Ongphiphadhanakul B. Comparisons of biochemical parameters and diabetic ketoacidosis severity in adult patients with type 1 and type 2 diabetes. BMC Endocr Disord. 2022;22(1) [Crossref]
110- Chávez J, Wijaya K, Pinto C, Burgos-Simón C. A model for type I diabetes in an HIV-infected patient under highly active antiretroviral therapy. Chaos, Solitons & Fractals. 2022;155:111716 [Crossref]
111- Rittiphairoj T, Owais M, Ward Z, Reddy C, Yeh J, Atun R. Incidence and prevalence of type 1 diabetes and diabetic ketoacidosis in children and adolescents (0–19 years) in Thailand (2015–2020): A nationwide population-based study. The Lancet Regional Health - Western Pacific. 2022;21:100392 [Crossref]
112- Rigo F. Left ventricular diastolic dysfunction in type 1 diabetes mellitus: the importance of being earlier. Int J Cardiovasc Imaging. 2022;38(9):1999 [Crossref]
113- Shubow S, Sun Q, Nguyen Phan A, Hammell D, Kane M, Lyman G, Gibofsky A, Lichtenstein G, Bloomgarden Z, Cross R, Yim S, Polli J, Wang Y. Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary. Clin Pharma and Therapeutics. 2022; [Crossref]
114- Sittadjody S, Opara E. Encapsulation Strategies for Pancreatic Islet Transplantation without Immune Suppression. Curr Stem Cell Rep. 2021;7(2):49 [Crossref]
115- Babakhanian M, Razavi A, Rahimi Pordanjani S, Hassanabadi S, Mohammadi G, Fattah A. High incidence of type 1 diabetes, type 2 diabetes and gestational diabetes in Central Iran: A six years results from Semnan health cohort. Annals of Medicine and Surgery. 2022;82:104749 [Crossref]
116- Kelly B. Nursing interventions for people with type 1 diabetes and frequent hypoglycaemia. Br J Community Nurs. 2021;26(11):544 [Crossref]
117- Zajec A, Trebušak Podkrajšek K, Tesovnik T, Šket R, Čugalj Kern B, Jenko Bizjan B, Šmigoc Schweiger D, Battelino T, Kovač J. Pathogenesis of Type 1 Diabetes: Established Facts and New Insights. Genes. 2022;13(4):706 [Crossref]
118- Govindarajan S, Zamir I, Bagewadi S, Moore E. Manifestation of glucose-6-phosphate dehydrogenase deficiency in the wake of new-onset type 1 diabetes mellitus: a case report. J Med Case Reports. 2022;16(1) [Crossref]
119- Quinn L, Wong F, Narendran P. Environmental Determinants of Type 1 Diabetes: From Association to Proving Causality. Front Immunol. 2021;12 [Crossref]
120- Walker S, Appari M, Forbes S. Considerations and challenges of islet transplantation and future therapies on the horizon. American Journal of Physiology-Endocrinology and Metabolism. 2022;322(2):E109 [Crossref]
121- Podichetty J, Lang P, O’Doherty I, David S, Muse R, Karpen S, Song L, Romero K, Burton J. Leveraging Real‐World Data for EMA Qualification of a Model‐Based Biomarker Tool to Optimize Type‐1 Diabetes Prevention Studies. Clin Pharma and Therapeutics. 2022;111(5):1133 [Crossref]
122- Kharbikar B, Mohindra P, Desai T. Biomaterials to enhance stem cell transplantation. Cell Stem Cell. 2022;29(5):692 [Crossref]
123- Senbanjo I, Akinola I, Umar U, Anyabolu C, Abolurin O, Adekoya A, Adeniyi O, Adepoju A, Salisu M, Gwarzo G, Olorunmoteni O, Ugowe O, Suwaid S, Ashubu O, Fetuga M, Oduwole A. Children and adolescents with type 1 diabetes mellitus in Nigeria: clinical characteristics and compliance with care. 2022;35(11):1377 [Crossref]
124- Fathi A, Babaei S, Babaei S, Baazm M, Sakhaie H, Babaei S. Effect of bromelain on mast cell numbers and degranulation in diabetic rat wound healing. J Wound Care. 2022;31(Sup8):S4 [Crossref]
125- Mushcab H, Alsharif F, Nazeer A, Mollah A, Matroud A, Qahtani S, Ghamdi M. Tawazon- An Intensive Lifestyle Diabetes Prevention Program: The Saudi Arabian Pilot. JMDH. 2021;Volume 14:2767 [Crossref]
126- Akhlaghipour I, Bina A, Mogharrabi M, Fanoodi A, Ebrahimian A, Khojasteh Kaffash S, Babazadeh Baghan A, Khorashadizadeh M, Taghehchian N, Moghbeli M. Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population. Hum Genomics. 2022;16(1) [Crossref]
127- Du C, Whiddett R, Buckle I, Chen C, Forbes J, Fotheringham A. Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development. Cells. 2022;11(21):3503 [Crossref]
128- Koltuntseva I, Novikova V, Revnova M, Gaiduk I, Khavkin A. Autoimmune gastritis in children with type I diabetes mellitus. jour. 2022;(6):27 [Crossref]
129- van Straalen J, de Roock S, Giancane G, Alexeeva E, Koskova E, Mesa-del-Castillo Bermejo P, Zulian F, Civino A, Montin D, Wulffraat N, Ruperto N, Swart J. Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registry. Pediatr Rheumatol. 2022;20(1) [Crossref]
130- Verhoeff K, Marfil-Garza B, Shapiro A. Update on islet cell transplantation. 2021;Publish Ahead of Print [Crossref]
131- Liu H, Sridhar V, Perkins B, Rosenstock J, Cherney D. SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis. Curr Diab Rep. 2022;22(7):317 [Crossref]
132- Kelaini S, Chan C, Cornelius V, Margariti A. RNA-Binding Proteins Hold Key Roles in Function, Dysfunction, and Disease. Biology. 2021;10(5):366 [Crossref]
133- Verduci E, Mameli C, Amatruda M, Petitti A, Vizzuso S, El Assadi F, Zuccotti G, Alabduljabbar S, Terranegra A. Early Nutrition and Risk of Type 1 Diabetes: The Role of Gut Microbiota. Front Nutr. 2020;7 [Crossref]
134- Chiang Y, Chang C, Yu H, Tsay P, Lo F, Chen C, Lin W, Hsu C, An C, Moons P. Developing the “Healthcare CEO App” for patients with type 1 diabetes transitioning from adolescence to young adulthood: A mixed‐methods study . Nursing Open. 2022; [Crossref]
135- Kaushik A, Sangtani R, Parmar H, Bala K. Algal metabolites: Paving the way towards new generation antidiabetic therapeutics. Algal Research. 2022;:102904 [Crossref]
136- Passanisi S, Pecoraro M, Pira F, Alibrandi A, Donia V, Lonia P, Pajno G, Salzano G, Lombardo F. Quarantine Due to the COVID-19 Pandemic From the Perspective of Pediatric Patients With Type 1 Diabetes: A Web-Based Survey. Front Pediatr. 2020;8 [Crossref]
137- Dial A, Monaco C, Grafham G, Patel T, Tarnopolsky M, Hawke T. Impaired Function and Altered Morphology in the Skeletal Muscles of Adult Men and Women With Type 1 Diabetes. 2021;106(8):2405 [Crossref]
138- Aberer F, Pieber T, Eckstein M, Sourij H, Moser O. Glucose-Lowering Therapy beyond Insulin in Type 1 Diabetes: A Narrative Review on Existing Evidence from Randomized Controlled Trials and Clinical Perspective. Pharmaceutics. 2022;14(6):1180 [Crossref]
139- Montt-Blanchard D, Dubois-Camacho K, Costa-Cordella S, Sánchez R. Domesticating the condition: Design lessons gained from a marathon on how to cope with barriers imposed by type 1 diabetes. Front Psychol. 2022;13 [Crossref]
140- Ganasegeran K, Hor C, Jamil M, Suppiah P, Noor J, Hamid N, Chuan D, Manaf M, Ch’ng A, Looi I. Mapping the Scientific Landscape of Diabetes Research in Malaysia (2000–2018): A Systematic Scientometrics Study. IJERPH. 2021;18(1):318 [Crossref]
141- Lin Y, Richardson C, Dobrin I, Pop-Busui R, Piatt G, Piette J. Accessibility and Openness to Diabetes Management Support With Mobile Phones: Survey Study of People With Type 1 Diabetes Using Advanced Diabetes Technologies. JMIR Diabetes. 2022;7(2):e36140 [Crossref]
142- Perumal N, Padidela R. Bone health assessment in children with type 1 diabetes using dual-energy X-ray absorptiometry scans: What is known and the way forward. JPED. 2022;2:4 [Crossref]
143- Iheagwam F, Iheagwam O, Onuoha M, Ogunlana O, Chinedu S. Terminalia catappa aqueous leaf extract reverses insulin resistance, improves glucose transport and activates PI3K/AKT signalling in high fat/streptozotocin-induced diabetic rats. Sci Rep. 2022;12(1) [Crossref]
144- Ferizi L, Bimbashi V, Kelmendi J. Association between metabolic control and oral health in children with type 1 diabetes mellitus. BMC Oral Health. 2022;22(1) [Crossref]
145- Prapa I, Yanni A, Nikolaou A, Kostomitsopoulos N, Kalogeropoulos N, Bezirtzoglou E, Karathanos V, Kourkoutas Y. Dietary Pistachio (Pistacia vera L.) Beneficially Alters Fatty Acid Profiles in Streptozotocin-Induced Diabetic Rat. Applied Sciences. 2022;12(9):4606 [Crossref]
146- Lee S, Washburn D, Colwell B, Gwarzo I, Kellstedt D, Ahenda P, Maddock J. Examining social determinants of undiagnosed diabetes in Namibia and South Africa using a behavioral model of health services use. Diabetes Research and Clinical Practice. 2021;175:108814 [Crossref]
147- Matuszewski W, Gontarz-Nowak K, Harazny J, Bandurska-Stankiewicz E. Evaluation of Morphological Changes in Retinal Vessels in Type 1 Diabetes Mellitus Patients with the Use of Adaptive Optics. Biomedicines. 2022;10(8):1926 [Crossref]
148- Smith F, Sabri A, Heppel M, Fonseca I, Chowdhury F, Cheung K, Willmor S, Rawson F, Marlow M. The clinical and translational prospects of microneedle devices, with a focus on insulin therapy for diabetes mellitus as a case study. International Journal of Pharmaceutics. 2022;628:122234 [Crossref]
149- Resurrección D, Navas-Campaña D, Gutiérrez-Colosía M, Ibáñez-Alfonso J, Ruiz-Aranda D. Psychotherapeutic Interventions to Improve Psychological Adjustment in Type 1 Diabetes: A Systematic Review. IJERPH. 2021;18(20):10940 [Crossref]
150- Harding J, Wander P, Zhang X, Li X, Karuranga S, Chen H, Sun H, Xie Y, Oram R, Magliano D, Zhou Z, Jenkins A, Ma R. The Incidence of Adult-Onset Type 1 Diabetes: A Systematic Review From 32 Countries and Regions. 2022;45(4):994 [Crossref]
151- Holt R, DeVries J, Hess-Fischl A, Hirsch I, Kirkman M, Klupa T, Ludwig B, Nørgaard K, Pettus J, Renard E, Skyler J, Snoek F, Weinstock R, Peters A. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021;64(12):2609 [Crossref]
152- M, Zhou Y, Takagi T, Tian Y. Safety, efficacy, and cost-effectiveness of insulin degludec U100 versus insulin glargine U300 in adults with type 1 diabetes: a systematic review and indirect treatment comparison. Int J Clin Pharm. 2022;44(3):587 [Crossref]
153- Passanisi S, Salzano G, Aloe M, Bombaci B, Citriniti F, De Berardinis F, De Marco R, Lazzaro N, Lia M, Lia R, Mammì F, Stamati F, Toscano R, Ventrici C, Iafusco D, Lombardo F. Increasing trend of type 1 diabetes incidence in the pediatric population of the Calabria region in 2019–2021. Ital J Pediatr. 2022;48(1) [Crossref]
154- Frommer L, Kahaly G. Type 1 Diabetes and Autoimmune Thyroid Disease—The Genetic Link. Front Endocrinol. 2021;12 [Crossref]
155- De Maria M, Fabrizi D, Luciani M, Caruso R, Di Mauro S, Riegel B, Barbaranelli C, Ausili D. Further Evidence of Psychometric Performance of the Self-care of Diabetes Inventory in Adults With Type 1 and Type 2 Diabetes. 2022;56(6):632 [Crossref]
156- Furthner D, Lukas A, Schneider A, Mörwald K, Maruszczak K, Gombos P, Gomahr J, Steigleder-Schweiger C, Weghuber D, Pixner T. The Role of Protein and Fat Intake on Insulin Therapy in Glycaemic Control of Paediatric Type 1 Diabetes: A Systematic Review and Research Gaps. Nutrients. 2021;13(10):3558 [Crossref]
157- Karpen S, Dunne J, Frohnert B, Marinac M, Richard C, David S, O’Doherty I. Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies. Diabetologia. 2022; [Crossref]
158- Zishan M, Mohamed M, Hossain C, Ahasan R, Sharun S. Design and Deployment of E-Health System Using Machine Learning in the Perspective of Developing Countries. 2022;13(1):1 [Crossref]
159- Ibrahim M, Parveen B, Zahiruddin S, Gautam G, Parveen R, Khan M, Gupta A, Ahmad S. Analysis of polyphenols in Aegle marmelos leaf and ameliorative efficacy against diabetic mice through restoration of antioxidant and anti‐inflammatory status . Journal of Food Biochemistry. 2022;46(4) [Crossref]
160- Bartolome A, Prioleau T. A computational framework for discovering digital biomarkers of glycemic control. npj Digit Med. 2022;5(1) [Crossref]
161- Battelino T, Danne T, Edelman S, Choudhary P, Renard E, Westerbacka J, Mukherjee B, Pilorget V, Coudert M, Bergenstal R. C ontinuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ ml versus insulin degludec 100 units/ ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial . Diabetes Obesity Metabolism. 2022; [Crossref]
162- Galosi E, Hu X, Michael N, Nyengaard J, Truini A, Karlsson P. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review. Acta Diabetol. 2022;59(1):1 [Crossref]
163- Ozana V, Hruska K, Sechi L. Neglected Facts on Mycobacterium Avium Subspecies Paratuberculosis and Type 1 Diabetes. IJMS. 2022;23(7):3657 [Crossref]
164- Bucsa C, Farcas A, Iaru I, Mogosan C, Rusu A. Drug utilisation study of antidiabetic medication during 2012‐2019 in Romania. Int J Clin Pract. 2021;75(11) [Crossref]

Indexing and Abstracting

Image result for esci

  Image result for scopus

     Linked in Profile

   Academia Profile

Officially associated with

The Iranian Health Education & Promotion Association



Publication Advantages

Free of charge publication

Open access 

Fast and constructive peer review

Easy and fast online submission